Streptococcus pneumoniae induces expression of the antibacterial CXC chemokine MIG/CXCL9 via MyD88-dependent signaling in a murine model of airway infection

Microbes and Infection

Volumn 12, Issue 7, 2010, Pages 565-573

  Eliasson, Mette ^a   Mörgelin, Matthias ^a   Farber, Joshua M ^b   Egesten, Arne ^a   Albiger, Barbara ^a  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antibacterial chemokines; Epithelial cells; Gram positive bacteria; Innate immunity; Streptococcus pneumoniae; Toll like receptors

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDE DERIVATIVE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ANIMALS; ANTI-INFECTIVE AGENTS; CHEMOKINE CXCL9; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PNEUMONIA, PNEUMOCOCCAL; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

MURINAE; MUS; POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 77953011315     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.03.014     Document Type: Article

References (25)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., Lee E., Mulholland K., Levine O.S., and Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374 (2009) 893-902
2. Albiger B., Dahlberg S., Henriques-Normark B., and Normark S. Role of the innate immune system in host defense against bacterial infections: focus on the toll-like receptors. J. Intern. Med. 261 (2007) 511-528
3. Albiger B., Dahlberg S., Sandgren A., Wartha F., Beiter K., Katsuragi H., Akira S., Normark S., and Henriques-Normark B. Toll-like receptor 9 acts at an early stage in host defense against pneumococcal infection. Cell Microbiol. 9 (2007) 633-644
4. Albiger B., Sandgren A., Katsuragi H., Meyer-Hoffert U., Beiter K., Wartha F., Hornef M., Normark S., and Normark B.H. Myeloid differentiation factor 88-dependent signaling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell Microbiol. 7 (2005) 1603-1615
5. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., Kurt-Jones E., Paton J.C., Wessels M.R., and Golenbock D.T. Recognition of pneumolysin by toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U S A 100 (2003) 1966-1971
6. Viola A., and Luster A.D. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 171-197
7. Eliasson M., and Egesten A. Antibacterial chemokines-actors in both innate and adaptive immunity. Contrib. Microbiol. 15 (2008) 101-117
8. Sauty A., Dziejman M., Taha R.A., Iarossi A.S., Neote K., Garcia-Zepeda E.A., Hamid Q., and Luster A.D. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162 (1999) 3549-3558
9. Egesten A., Eliasson M., Johansson H.M., Olin A.I., Morgelin M., Mueller A., Pease J.E., Frick I.M., and Bjorck L. The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J. Infect. Dis. 195 (2007) 684-693
10. Linge H.M., Sastalla I., Nitsche-Schmitz D.P., Egesten A., and Frick I.M. Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect. Microbiology 153 (2007) 3800-3808
11. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
12. Qian Y.Q., Johanson K.O., and McDevitt P. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8. J. Mol. Biol. 294 (1999) 1065-1072
13. Eswar N., John B., Mirkovic N., Fiser A., Ilyin V.A., Pieper U., Stuart A.C., Marti-Renom M.A., Madhusudhan M.S., Yerkovich B., and Sali A. Tools for comparative protein structure modeling and analysis. Nucleic Acids Res. 31 (2003) 3375-3380
14. Eswar N., Webb B., Marti-Renom M.A., Madhusudhan M.S., Eramian D., Shen M.Y., Pieper U., and Sali A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinformatics. (2006) (Chapter 5:Unit 5 6)
15. Eswar N., Webb B., Marti-Renom M.A., Madhusudhan M.S., Eramian D., Shen M.Y., Pieper U., and Sali A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. (2007) (Chapter 2:Unit 2 9)
16. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA
17. Tsai K.S., and Grayson M.H. Pulmonary defense mechanisms against pneumonia and sepsis. Curr. Opin. Pulm. Med. 14 (2008) 260-265
18. Mahalingam S., Chaudhri G., Tan C.L., John A., Foster P.S., and Karupiah G. Transcription of the interferon gamma (IFN-gamma)-inducible chemokine Mig in IFN-gamma-deficient mice. J. Biol. Chem. 276 (2001) 7568-7574
19. Ohmori Y., Schreiber R.D., and Hamilton T.A. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J. Biol. Chem. 272 (1997) 14899-14907
20. Gratz N., Siller M., Schaljo B., Pirzada Z.A., Gattermeier I., Vojtek I., Kirschning C.J., Wagner H., Akira S., Charpentier E., and Kovarik P. Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J. Biol. Chem. 283 (2008) 19879-19887
21. Mancuso G., Gambuzza M., Midiri A., Biondo C., Papasergi S., Akira S., Teti G., and Beninati C. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10 (2009) 587-594
22. Liljeroos M., Vuolteenaho R., Rounioja S., Henriques-Normark B., Hallman M., and Ojaniemi M. Bacterial ligand of TLR2 signals Stat activation via induction of IRF1/2 and interferon-alpha production. Cell Signal 20 (2008) 1873-1881
23. Zeng X., Moore T.A., Newstead M.W., Deng J.C., Kunkel S.L., Luster A.D., and Standiford T.J. Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia. Infect. Immun. 73 (2005) 8226-8236
24. + T cells. Infect. Immun. 76 (2008) 2678-2684
25. + T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. U S A 102 (2005) 4848-4853